MedPath

Herbal Preparation Used as Adjuvant Therapy on Diabetic Ulcers

Phase 2
Completed
Conditions
Diabetic Foot Ulcer
Amputation
Interventions
Drug: TCM
Drug: Placebo
Registration Number
NCT00393510
Lead Sponsor
Chinese University of Hong Kong
Brief Summary

Chronic foot ulcers occurring among diabetic patients are difficult to heal. The frequent elderly age with co-morbidities, vascular insufficiencies, peripheral neuropathies and super imposed infections, all contribute towards the chronicity and failure of treatment. Preserving the ulcerated limb is the patients' wish. On the other hand, an infected ulcer that never heals just unnecessarily prolongs suffering. Nevertheless, patients earnestly like to try all methods of healing before accepting amputation.

Objective:To determine whether a course of herbal preparation used as an adjuvant therapy for diabetic patients suffering from chronic foot ulcers may promote healing so that major leg amputation can be avoided.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Well Controlled diabetic state
  • Presence of gangrene or non-healing ulcer in diabetic patients over the foot or feet. Infection should be well controlled.
  • Good glycaemic control
Read More
Exclusion Criteria
  • Pregnant women and women at risk of conception
  • Patients taking digitalis glycosides
  • Patients with abnormal liver function tests
  • Patients with plasma creatinine great then 150 umol/l or unstable renal function
  • Poorly controlled Diabetes Mellitus
  • Uncontrolled infection
  • History of adverse reaction to herbal medicine
  • Unstable medical conditions
  • Non-compliance with regime
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Traditional Chinese MedicineTCM12 herbals formulation was given as an adjuvant therapy for the patients orally twice a day.
PlaceboPlaceboPlacebo was made with starch and colouring materials. Given to patient orally twice a day
Primary Outcome Measures
NameTimeMethod
Number of Participants With Limb Salvage24 weeks

The number of successful limb rescued (without amputation).

Secondary Outcome Measures
NameTimeMethod
Tumour Necrosis Factor-alpha Levels in SerumBaseline and 4 week

The state of inflammation at baseline and at 4 weeks after treatment. TNF-alpha are in value of serum level.

Time of Ulcer Healing24 week

Time taken for maturation of granulation to enable skin grafting.

Trial Locations

Locations (2)

Department of Orthopaedics and Traumatology, Kwong Wah Hospital

🇨🇳

Hong Kong, China

Department of Orthopaedics & Traumatology, Prince of Wales hospital

🇨🇳

Hong Kong, China

© Copyright 2025. All Rights Reserved by MedPath